Genentech is soliciting research that can be used to blunt pharma reforms in Washington While such overtures are not uncommon, the company is being unusually direct about its interests

https://www.statnews.com/pharmalot/2026/05/22/genentech-soliciting-academics-write-papers-to-blunt-pharma-reforms-dc/ By Ed SilvermanMay 22, 2026 Pharmalot Columnist, Senior Writer